ERBB2 and breast carcinoma: For determining molecular targeted therapy of breast cancer, for example, such markers as estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor-2 (HER2), and Ki-67 are consistently immunostained [13].